|
|||||
|
|
A Randomized,Double‐Blind,Placebo‐Controlled,Twelve‐Week,Dose‐Ranging Study of Decernotinib,an Oral Selective JAK‐3 Inhibitor,as Monotherapy in Patients With Active Rheumatoid Arthritis |
|
| Authors: | Roy M Fleischmann Nemanja S Damjanov Alan J Kivitz Anna Legedza Thomas Hoock Nils Kinnman |
| Abstract: | |
| Keywords: | |